Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”?-Reference-Cited by-同舟云学术

Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”?

Published:2017-03 Issue:2 Volume:5 Page:535
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Liccardi Gennaro,Calzetta Luigino,Salzillo Antonello,Apicella Gerardo,Cavalli Francesco,Rogliani Paola

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference7 articles.

1. H1-antihistamine premedication in NSAID- associated urticaria;Trautmann;J Allergy Clin Immunol Pract,2016

2. Classification and practical approach to the diagnosis and management of hypersensitivity to non-steroidal anti-inflammatory drugs;Kovalski;Allergy,2013

3. The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine;Bousquet;Allergy,2004

4. Aerius, INN-desloratadine. European Medicines Agency. Europa. Available from: www.ema.europa.eu/docs/en_GB/.../WC500025540. Accessed November 11, 2016.

5. Phenylalanine-free tastemasked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers;Yehia;Pharm Dev Technol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of modern second-generation antihistamines;Glavvrač (Chief Medical Officer);2023-01-01

2. Does synthetic pharmacotherapy still have a place in treating chronic spontaneous urticaria?;Expert Opinion on Pharmacotherapy;2022-09-22

3. Chronic Urticaria with NSAID-Exacerbated Cutaneous Disease: A (NSAID) Challenge Worth Taking;The Journal of Allergy and Clinical Immunology: In Practice;2020-11

4. Clinical Control of CSU with Antihistamines Allows for Tolerance of NSAID-Exacerbated Cutaneous Disease;The Journal of Allergy and Clinical Immunology: In Practice;2020-11

5. Second generation antihistamines: an update;Current Opinion in Allergy & Clinical Immunology;2019-08